Shamkhi Abbood Mustafa, Shamkhee Eftekhar, Abbas Hammadi Samah
Department of General Surgery, College of Medicine, Ibn Sina University of Medical and Pharmaceutical Sciences, Baghdad, Iraq.
Department of Gynecology, College of Medicine, Ibn Sina University of Medical and Pharmaceutical Sciences, Baghdad, Iraq.
Iran J Otorhinolaryngol. 2024;36(6):669-674. doi: 10.22038/ijorl.2024.76230.3553.
Epistaxis is common throughout pregnancy and is usually not a cause for concern; severe nosebleeds are rare. An increased rate of nasal bleeding was observed during the COVID-19 epidemic.
The study sample comprised 3,362 pregnant women who sought care at the Gynecologic and Obstetrics Department/ Al-Yarmouk Teaching Hospital and Al-Karkh Maternity Hospital between May 2020 and April 2021. All were asked to fill out a questionnaire.
Nine hundred forty-one pregnant women experienced an episode of epistaxis during the last pregnancy. One thousand seven hundred forty-eight pregnant women had a corona-positive history. Pregnant women with a positive history of coronavirus infection have a higher incidence of epistaxis (612 pregnant women) than pregnant women with a corona-negative history (329 pregnant women) P value (0.039%).
Oxygen and blood-thinning drugs are the leading causes of the increased rate of nosebleeds among pregnant women during the Corona pandemic.
鼻出血在整个孕期都很常见,通常无需担忧;严重鼻出血很少见。在新冠疫情期间观察到鼻出血发生率有所增加。
研究样本包括2020年5月至2021年4月期间在雅尔穆克教学医院妇产科和卡尔赫妇产医院就诊的3362名孕妇。所有孕妇均被要求填写一份问卷。
941名孕妇在末次妊娠期间经历过鼻出血。1748名孕妇有新冠阳性病史。有新冠病毒感染阳性病史的孕妇鼻出血发生率(612名孕妇)高于新冠阴性病史的孕妇(329名孕妇),P值为0.039%。
氧气和血液稀释药物是新冠疫情期间孕妇鼻出血发生率增加的主要原因。